Clinical validation of the Hilab lens for AI supported point of care CBC testing in pediatric oncology.

ABSTRACT:

Background

Complete blood count (CBC) testing is critical for diagnosing and monitoring hematological conditions, including leukemia. However, conventional analyzers require specialized infrastructure and trained personnel, limiting access in resource-constrained settings. Point-of-care hematology devices provide a promising alternative by delivering rapid results with minimal complexity. This study aimed to evaluate the analytical performance of the Hilab Lens versus XE-2100.

Methods

Blood samples (n = 555) were analyzed using both devices at Erastinho Hospital, a pediatric oncology center. Device performance was assessed through precision testing, method comparison, sample type equivalence, evaluation of potential interferences, and caregiver satisfaction surveys. Agreemen

SUBMITTER: Gasparin AT 

PROVIDER: S-EPMC12680630 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature